Loading organizations...

§ Private Profile · Berlin, Germany
SaaS platform curating and delivering ML-ready biomedical molecular data for drug discovery teams, focused on multi-omic datasets.
Based in San Francisco, California, Elucidata provides a specialized software as a service platform that curates and delivers machine learning ready biomedical molecular data to accelerate pharmaceutical drug discovery. The company's primary code-first platform, known as Polly, currently hosts over 230,000 multi-omic datasets and processes an additional 50,000 new datasets monthly to assist data-driven life sciences teams. Operating with a global workforce of 148 employees across offices in the United States and India, the enterprise utilizes natural language processing and machine learning to simplify complex data wrangling. Elucidata has secured $24 million in total venture funding from financial backers including IvyCap Ventures, while its leadership actively engages with prominent industry communities such as Bits in Bio on Slack. The biomedical technology organization was officially founded in 2015 by co-founders Abhishek Jha, Swetabh Pathak, and Dick Kibbey.
Elucidate has raised $19.0M across 3 funding rounds.
Elucidate has raised $19.0M in total across 3 funding rounds.
Elucidate has raised $19.0M in total across 3 funding rounds.
Elucidate's investors include Baris Aksoy, Tommy Nicholas, APEX Ventures, BiG Start Ventures, Elevator Ventures, Frontline Ventures, SixThirty, AV8 Ventures, 8VC, Lightspeed India Partners, Red Ventures, Pratyus Patnaik.
# High-Level Overview
The search results reveal multiple companies operating under the "Elucidate" name, each serving distinct markets. The most prominent is Elucidate, a financial crime risk management platform founded in 2018 and based in Berlin, Germany.[1] The company enables financial institutions to leverage their own data to assess and predict financial crime risks—including money laundering, terrorist financing, trafficking, and tax evasion.[1] It serves network and domestic banks requiring risk management and compliance frameworks, and has recently launched a financial crime risk pricing product.[1]
Two other companies share the Elucidate name but operate in entirely different sectors: Elucidate Technologies in India specializes in geospatial data analytics, GIS, and LiDAR solutions for government and enterprise clients;[2] and Elucidate Technologies, Inc. in Puerto Rico provides IT support and solutions delivery to small and medium-sized businesses.[3][4]
# Origin Story
The Berlin-based financial crime risk management company was founded in 2018, positioning itself at the intersection of fintech and regulatory compliance during a period of heightened focus on anti-money laundering (AML) and know-your-customer (KYC) requirements across financial services.[1] The company emerged to address a critical gap: enabling financial institutions to harness their own internal data for predictive risk assessment rather than relying solely on external compliance tools.
The company has secured funding to expand its operations, with plans to grow its revenue, operations, and data-science teams across Europe and the United States.[1] This growth trajectory reflects investor confidence in the financial crime compliance market and the demand for AI-driven risk solutions.
# Core Differentiators
# Role in the Broader Tech Landscape
Elucidate operates within the rapidly expanding fintech compliance and risk management sector, where regulatory pressure, digital transformation, and the rise of cryptocurrency and cross-border payments have created urgent demand for sophisticated risk tools.[1] The company competes alongside platforms like Unit21 (transaction monitoring and fraud prevention), Sayari (supply chain risk intelligence), and Black Ice AI (AI-driven compliance), indicating a crowded but growing market.[1]
The timing is critical: financial institutions face mounting regulatory fines for AML/KYC failures, making predictive risk management increasingly valuable. Elucidate's focus on enabling banks to monetize their own data through risk pricing represents a shift toward more sophisticated, data-native compliance infrastructure—aligning with broader trends in AI-driven financial services.
# Quick Take & Future Outlook
Elucidate is well-positioned to capture market share in the financial crime risk management space, particularly as banks seek to move beyond reactive compliance toward predictive, data-driven risk frameworks. The launch of its risk pricing product suggests the company is evolving from a compliance tool into a strategic risk intelligence platform—a higher-value positioning that could drive stronger unit economics and customer stickiness.
The company's expansion into the United States and continued investment in data-science talent indicate ambitions to scale beyond European markets. As regulatory scrutiny intensifies globally and financial institutions prioritize AI-driven risk management, Elucidate's ability to deliver actionable intelligence from proprietary data could become a critical competitive advantage in an increasingly crowded compliance tech landscape.
Elucidate has raised $19.0M across 3 funding rounds. Most recently, it raised $8.0M Other Equity in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 12, 2022 | $8M Venture Round | Baris Aksoy | Tommy Nicholas, APEX Ventures, BIG Start Ventures, Elevator Ventures, Frontline Ventures, SixThirty | Announced |
| May 1, 2022 | $8M Seed | AV8 Ventures | 8VC, Lightspeed India Partners, RED Ventures, Pratyus Patnaik, APEX Ventures, BIG Start Ventures, Elevator Ventures, Frontline Ventures, SixThirty, Tommy Nicholas | Announced |
| Mar 1, 2021 | $3M Seed | Will Prendergast | Pratyus Patnaik, APEX Ventures, BIG Start Ventures, Seed X | Announced |